For most women, 3D mammography (also called digital breast tomosynthesis) is the best option for routine breast cancer screening. It detects one to two additional cancers per 1,000 women screened compared to standard 2D mammography, and it reduces the number of women called back for false alarms. That said, the “best” mammogram depends on why you’re getting one, what your breast tissue looks like, and what your doctor is looking for.
3D vs. 2D Mammography
A standard 2D mammogram takes two flat X-ray images of each breast, one from top to bottom and one from side to side. A 3D mammogram takes multiple images in thin slices, then reconstructs them into a layered picture the radiologist can scroll through. Think of it like flipping through pages of a book versus looking at the cover. Overlapping tissue that might hide a small tumor on a flat image gets separated out in 3D, making suspicious areas easier to spot.
Across all breast densities, 3D mammography finds roughly one to two more cancers per 1,000 women screened and reduces recall rates to about 84 per 1,000, meaning fewer women get that anxiety-inducing callback for additional imaging that turns out to be nothing. The radiation dose is comparable: studies show 2D mammograms deliver roughly 1.4 to 1.7 milligrays per exposure, while 3D scans fall in a similar range of about 1.7 to 1.9 milligrays. That small difference is well within safety limits.
One important caveat: for lesions already flagged as suspicious and heading toward biopsy, 3D mammography doesn’t appear to outperform 2D. A study in the European Journal of Radiology found no significant difference in cancer detection or in reducing unnecessary biopsies once a lesion had already been classified as probably suspicious. The real advantage of 3D is in the initial screening stage, where it helps radiologists decide what deserves a closer look in the first place.
Why Breast Density Matters
About half of women who get mammograms have dense breast tissue. Density is determined by the ratio of fibrous and glandular tissue to fatty tissue, and you can’t feel the difference from the outside. Your mammogram report will tell you if your breasts are dense.
Dense tissue and tumors both show up white on a mammogram, which is like trying to find a snowball in a snowstorm. This makes mammography less sensitive in women with dense breasts, meaning it’s more likely to miss a cancer. Dense tissue also independently raises your risk of developing breast cancer in the first place, so the stakes are higher and the test is less reliable at the same time.
You might expect clear guidance on what additional screening dense-breasted women should get, but the U.S. Preventive Services Task Force says there isn’t yet enough evidence to recommend for or against supplemental tests like ultrasound or MRI for this group. That doesn’t mean those tools don’t help. It means the research hasn’t definitively shown that the benefits (catching more cancers) outweigh the harms (more false positives, more biopsies that turn out benign). If you have dense breasts, this is a conversation worth having with your doctor about your individual risk factors.
Screening vs. Diagnostic Mammograms
These aren’t different technologies. They’re different purposes for the same machine. A screening mammogram is what you get annually or every two years when you have no symptoms and no known problems. It captures a standard set of images, takes about 20 minutes, and a radiologist reads the results later.
A diagnostic mammogram happens when something needs investigating: a lump you or your doctor felt, an abnormal screening result, nipple discharge, or breast pain. The technologist takes more images from additional angles and may use magnification or spot compression to zoom in on a specific area. It takes longer, delivers a slightly higher radiation dose because of the extra images, and a radiologist often reads the results in real time so they can request more views if needed. Women with breast implants are also typically sent for diagnostic mammograms, since implants can obscure tissue on standard screening images.
You don’t choose between these two. Your doctor orders whichever one fits your situation.
Contrast-Enhanced Mammography
Contrast-enhanced mammography is a newer option that combines a mammogram with an injection of iodine-based contrast dye, similar to what’s used in CT scans. Tumors tend to have increased blood flow, so the dye lights them up on the image. This gives radiologists both the structural detail of a standard mammogram and the functional information about blood supply that you’d normally need an MRI to see.
This type of mammogram isn’t used for routine screening. Its most common uses are sorting out inconclusive findings from a standard mammogram, staging cancer before surgery, and monitoring how a tumor responds to treatment. It’s also a practical alternative for women who need breast MRI but can’t have one due to claustrophobia, a pacemaker, or metallic implants. Studies suggest its diagnostic performance is comparable to MRI in many of these scenarios.
The tradeoff is that iodine contrast carries its own risks. Women with prior allergic reactions to contrast dye or those with kidney problems should avoid it, since the contrast can cause kidney injury in vulnerable patients. In those cases, MRI remains the safer choice.
AI-Assisted Mammogram Reading
Some imaging centers now use artificial intelligence algorithms as a second reader alongside the radiologist. These systems analyze mammogram images and flag areas that look suspicious. The best-performing AI models in large evaluations achieved a sensitivity of about 49% with a specificity of 99.5%, meaning they correctly identified roughly half of cancers while producing very few false alarms. They performed notably better on invasive cancers (57% sensitivity) than on non-invasive ones (30%).
AI doesn’t replace the radiologist. It functions more like a safety net, potentially catching cancers that a human reader might overlook, particularly in high-volume practices where radiologists read hundreds of mammograms a day. You likely won’t know whether AI was used in your reading unless you ask, and it’s not something you can specifically request at most facilities yet.
Current Screening Guidelines
The USPSTF recommends that women ages 40 to 74 get a screening mammogram every two years. For women 75 and older, the task force says there isn’t enough evidence to make a recommendation either way. The American Cancer Society takes a slightly different approach, recommending annual mammograms starting at 45, with the option to start at 40 and switch to every two years at 55.
Neither set of guidelines specifies 2D versus 3D. In practice, 3D mammography is now used for the majority of screening in the United States, and most facilities have made the switch.
Cost and Insurance Coverage
Under the Affordable Care Act, screening mammograms are covered as a preventive service with no out-of-pocket cost. However, the ACA doesn’t explicitly include 3D mammograms in that requirement, which has left coverage decisions to individual states and insurers. Many states have passed laws requiring insurers to cover 3D mammograms the same way they cover 2D, often prohibiting copays and deductibles for the service.
Where 3D mammograms aren’t fully covered, the out-of-pocket difference has historically been modest. Data from Minnesota before its coverage mandate showed average patient cost-sharing of about $11 for a 3D mammogram compared to roughly $3 for a standard one. After the state required equal coverage, the 3D cost dropped to about $2.70 per procedure. If you’re unsure about your coverage, call your insurance company before scheduling, and ask specifically whether digital breast tomosynthesis is covered as preventive screening.